Fresenius Medical Care AG & Co. KGaA
HealthcareNYSE:FMS · New York Stock Exchange
+$0.65 today
Vol 0.57M · Avg 0.77M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$19.4B of revenue converted into $944.7M of net income for the selected period. Gross margin is 25.9% and net margin is 4.8%, showing how much revenue survives after costs and taxes. EPS is $1.65, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.6B +1.5% | $19.3B -0.6% | $19.5B +0.3% | $19.4B +10.1% | $17.6B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $14.6B +0.1% | $14.6B +0.3% | $14.5B +0.2% | $14.5B +12.9% | $12.8B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $5.0B +5.7% | $4.8B -3.4% | $4.9B +0.6% | $4.9B +2.5% | $4.8B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 25.6% +1.0pp | 24.6% -0.7pp | 25.3% +0.1pp | 25.2% -1.9pp | 27.1% | 9.8% | 28.9% | 38.3% |
| Research & Development | $158.0M -13.9% | $183.5M -20.9% | $232.0M +1.5% | $228.6M +3.6% | $220.8M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $3.0B -3.5% | $3.1B -1.7% | $3.2B +0.8% | $3.2B +14.3% | $2.8B | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $3.2B -2.7% | $3.3B -7.5% | $3.6B +5.1% | $3.4B +15.8% | $2.9B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $1.5B -13.9% | $1.7B -0.6% | $1.8B -4.7% | $1.8B +13.2% | $1.6B | $374.2M | $1.2B | $631.8M |
| EBITDA | $3.4B +6.0% | $3.2B -0.1% | $3.2B -6.1% | $3.4B -3.7% | $3.5B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 17.3% +0.7pp | 16.6% +0.1pp | 16.5% -1.1pp | 17.6% -2.5pp | 20.1% | 5.6% | 46.3% | 42.0% |
| Operating Income | $1.8B +24.5% | $1.5B +7.2% | $1.4B -9.4% | $1.5B -18.4% | $1.9B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 9.3% +1.7pp | 7.6% +0.5pp | 7.0% -0.8pp | 7.8% -2.7pp | 10.5% | 16.6% | 24.1% | 22.0% |
| Interest Income | $69.6M -2.7% | $71.6M -18.9% | $88.2M +30.4% | $67.7M -7.5% | $73.2M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $384.4M -5.6% | $407.0M -4.1% | $424.6M +17.9% | $360.1M +1.8% | $353.6M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$314.6M +23.4% | -$410.5M -22.0% | -$336.4M -15.0% | -$292.5M -4.3% | -$280.4M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $1.5B +43.1% | $1.1B +2.3% | $1.0B -15.3% | $1.2B -22.4% | $1.6B | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 7.7% +2.2pp | 5.5% +0.2pp | 5.3% -1.0pp | 6.3% -2.6pp | 8.9% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $321.0M +1.6% | $316.1M +5.2% | $300.6M -7.5% | $325.0M -7.9% | $352.8M | $1.3B | -$1.6B | $745.2M |
| Net Income | $978.4M +81.9% | $537.9M +7.8% | $499.0M -25.9% | $673.4M -30.5% | $969.3M | $4.9B | $4.8B | $4.7B |
| Net Margin | 5.0% +2.2pp | 2.8% +0.2pp | 2.6% -0.9pp | 3.5% -2.0pp | 5.5% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $2 +82.6% | $1 +8.2% | $1 +49.1% | $1 -31.3% | $1 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $2 +82.6% | $1 +8.2% | $1 +49.1% | $1 -31.3% | $1 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $582.4M -0.9% | $587.9M +0.1% | $587.1M -50.0% | $1.2B +0.1% | $1.2B | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $582.4M -0.8% | $586.8M +0.0% | $586.8M -50.0% | $1.2B +0.1% | $1.2B | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Royalty Pharma plc
NASDAQ:RPRX
$23.60B
Hologic, Inc.
HOLX
$16.97B
Tenet Healthcare Corporation
NYSE:THC
$15.04B
Solventum Corporation
NYSE:SOLV
$13.66B
DaVita Inc.
NYSE:DVA
$13.40B
Smith & Nephew plc
NYSE:SNN
$12.97B
ICON Public Limited Company
NASDAQ:ICLR
$11.19B
Encompass Health Corporation
NYSE:EHC
$10.07B
Universal Health Services, Inc.
NYSE:UHS
$9.17B
Tempus AI, Inc.
NASDAQ:TEM
$8.35B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does FMS generate?
Fresenius Medical Care AG & Co. KGaA (FMS) reported $19.63B of revenue in fiscal 2025.
Is FMS profitable?
Fresenius Medical Care AG & Co. KGaA (FMS) reported $978.37M of net income, with a net margin of 5.0%.
Explore More
Continue the stock analysis
Jump to another research area for this company.